Brief: Interpace Biosciences Q4 Revenue USD 10.283 Million

Interpace Biosciences

07/03/2024 13:00

Mar 07 (Reuters) - Interpace Biosciences Q4 operating income USD 1.312
million.
* Q4 net income USD 889 thousand
* Q4 gross profit USD 6.136 million
* Q4 operating expenses USD 4.824 million
* Q4 net income continuing operations USD 813 thousand